ARCHIVES

Blincyto Demonstrates Response In Minimal Residual Disease ALL

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Center Seeks HER-2 Positive Breast Cancer Patients

August 29, 2003

NCI Advisors Approve Plan For Repository For Prostate Cancer Issue Specimens

March 19, 1999

NIH institute directors, in response to question from Sen. Arlen Specter, say Bush Administration’s stem cell research policy is harmful to NIH leadership in science.

April 8, 2005

NCI Advisors Approve $100M Set Aside for Physical Sciences-Oncology Centers.

December 12, 2008

FOCR Report Offers Recommendations, Definitions for CER

May 22, 2009

Agency Expands Gleevec Label To Include Rare GIST Subset

February 24, 2012